Yoga Interventions for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis - A Scoping Review
DOI:
https://doi.org/10.48165/IRJAY.2025.80902Keywords:
Yoga, Chronic Fatigue Syndrome, Myalgic Encephalomyelitis, Quality of Life, Fatigue, ReviewAbstract
Background: Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a debilitating multisystem disorder characterized by persistent fatigue, post-exertional malaise, cognitive impairment, and pain, while also imposing significant socioeconomic burdens. Present treatments are limited, leading to the exploration of complementary therapies, such as yoga, which may affect autonomic function, inflammation, and mental health. This study aimed to map the existing literature on yoga interventions for CFS/ME and identify study designs, interventions, outcomes, and evidence gaps. Materials and Methods: We searched PubMed, Cochrane Library, and Google Scholar from their inception to April 2025 for studies on adults with CFS/ME using yoga. The inclusion criteria encompassed any design that evaluated the effects of yoga on fatigue and its related outcomes. Data were extracted on design, participants, interventions, outcomes, and findings, with the results synthesized narratively and charted. Results: Six primary studies, primarily from a Japanese group, were included. The interventions focused on adapted isometric yoga (sitting/recumbent, 2–3 months, biweekly sessions plus home practice). In some cases, fatigue was consistently reduced with improvements in vigor, pain, depression, autonomic function, and biomarkers (e.g., tumor necrosis factor-α). Adverse events were minor and transient. To date, no qualitative or large-scale studies have been conducted. Conclusions: Adapted isometric yoga shows promise in reducing fatigue in CFS/ME; however, evidence is limited by small samples, single-group designs, and short follow-ups. Larger multicenter randomized controlled studies with standardized protocols and biomarkers are needed to confirm the efficacy and guide its clinical use.Downloads
References
Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: Essentials of diagnosis and management. Mayo Clin Proc. 2021;96(11):2861-2878. doi:10.1016/j.mayocp.2021.07.004
Komaroff AL. Advances in understanding the pathophysiology of chronic fatigue syndrome. JAMA. 2019;322(6):499-500. doi:10.1001/jama.2019.8312
Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121(12):953-959. doi:10.7326/0003-4819-121-12-199412150-00009
Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr. 2003;11(1):7-115. doi:10.1300/J092v11n01_02
Carruthers BM, Van De Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: International consensus criteria. J Intern Med. 2011;270(4):327-338. doi:10.1111/j.1365-2796.2011.02428.x
Institute of Medicine. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: Redefining an illness. Washington, DC: National Academies Press; 2015. doi:10.17226/19012
Haney E, Smith ME, McDonagh M, Pappas M, Daeges M, Wasson N, et al. Diagnostic methods for myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(12):834-840. doi:10.7326/M15-0443
Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. 2020;18(1):100. doi:10.1186/s12967-020-02269-0
Vahratian A, Lin JS, Bertolli J, Unger ER. Myalgic encephalomyelitis/chronic fatigue syndrome in adults: United States, 2021-2022. NCHS Data Brief. 2023;488:1-8.
Bakunina N, Pariante CM, Zunszain PA. Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology. 2015;144(3):365-373. doi:10.1111/imm.12443
Dehlia A, Guthridge MA. The persistence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) after SARS-CoV-2 infection: A systematic review and meta-analysis. J Infect. 2024;89(6):106297. doi:10.1016/j.jinf.2024.106297
Valdez AR, Hancock EE, Adebayo S, Kiernicki DJ, Proskauer D, Attewell JR, et al. Estimating prevalence, demographics, and costs of ME/CFS using large-scale medical claims data and machine learning. Front Pediatr. 2019;6:412. doi:10.3389/fped.2018.00412
Nacul L, O’Boyle S, Palla L, Nacul FE, Mudie K, Kingdon CC, et al. How myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) progresses: The natural history of ME/CFS. Front Neurol. 2020;11:826. doi:10.3389/fneur.2020.00826
Jason LA, Benton MC, Valentine L, Johnson A, Torres-Harding S. The economic impact of ME/CFS: Individual and societal costs. Dyn Med. 2008;7:6. doi:10.1186/1476-5918-7-6
Morris G, Berk M, Galecki P, Maes M. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Mol Neurobiol. 2014;49(2):741-756. doi:10.1007/s12035-013-8553-0
Missailidis D, Annesley SJ, Fisher PR. Pathological mechanisms underlying myalgic encephalomyelitis/chronic fatigue syndrome. Diagnostics (Basel). 2019;9(3):80. doi:10.3390/diagnostics9030080
Tak LM, Cleare AJ, Ormel J, Manoharan A, Kok IC, Wessely S, et al. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol Psychol. 2011;87(2):183-194. doi:10.1016/j.biopsycho.2011.02.002
Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A systematic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas). 2021;57(5):418. doi:10.3390/medicina57050418
Sharpe M, Goldsmith KA, Johnson AL, Chalder T, Walker J, White PD. Rehabilitative treatments for chronic fatigue syndrome: Long-term follow-up from the PACE trial. Lancet Psychiatry. 2015;2(12):1067-1074. doi:10.1016/S2215-0366(15)00317-X
Smith ME, Haney E, McDonagh M, Pappas M, Daeges M, Wasson N, et al. Treatment of myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(12):841-850. doi:10.7326/M15-0114


